Do tumor necrosis factor inhibitors cause uveitis? A registry-based study
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference37 articles.
1. Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents
2. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti–tumor necrosis factor therapy
3. Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
4. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
Cited by 259 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Factors associated with cause-specific discontinuation of long-term anti-tumor necrosis factor agent use in patients with ankylosing spondylitis: a retrospective cohort study;BMC Rheumatology;2024-08-30
2. EVALUATION OF DRUG SIDE EFFECT PROFILES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASE USING TUMOR NECROSIS FACTOR-ALPHA INHIBITORS;Rheumatology Quarterly;2024-05-21
3. Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist;Journal of Ophthalmic Inflammation and Infection;2024-04-10
4. Adverse events of biological agents in pediatric rheumatologic diseases;Postgraduate Medicine;2024-02-17
5. Comparison of Incidence or Recurrence of Anterior Uveitis in Patients with Ankylosing Spondylitis Treated with Tumor Necrosis Factor Inhibitors;Journal of Clinical Medicine;2024-02-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3